Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 10, Octobre 2015
Page(s) 853 - 860
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153110011
Publié en ligne 19 octobre 2015
  1. Prader A, Labhart A, Willi H. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatonieartigem zustand im neugeborenenalter. Schweiz Med Wochenschr 1956 ; 6 : 1260–1261.
  2. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med 2012 ; 14 : 10–26. [CrossRef] [PubMed]
  3. Miller JL, Lynch CH, Driscoll DC, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A 2011; 155A : 1040–1049. [CrossRef] [PubMed]
  4. Goldstone AP, Holland AJ, Hauffa BP, et al. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 2008 ; 93 : 4183–4197. [CrossRef] [PubMed]
  5. Butler JV, Whittington JE, Holland AJ, et al. The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood. Dev Med Child Neurol 2010 ; 52 : e88–e93. [CrossRef] [PubMed]
  6. Lacroix D, Moutel S, Coupaye M, et al. Metabolic and adipose-tissue signatures in adults with Prader-Willi syndrome, a model of extreme adiposity. J Clin Endocrinol Metab 2014 ; 100 : 850–859. [CrossRef] [PubMed]
  7. Coupaye M, Lorenzini F, Lloret-Linares C, et al. Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood. J Clin Endocrinol Metab 2013 ; 98 : E328–E335. [CrossRef] [PubMed]
  8. Laurier V, Lapeyrade A, Copet P, et al. Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France. J Intellect Disabil Res 2015 ; 59 : 411–421. [CrossRef] [PubMed]
  9. Mantoulan C, Payoux P, Diene G, et al. PET scan perfusion imaging in the Prader-Willi syndrome: new insights into the psychiatric and social disturbances. J Cereb Blood Flow Metab 2011 ; 31 : 275–282. [CrossRef] [PubMed]
  10. Miller JL, James GA, Goldstone AP, et al. Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome. J Neurol Neurosurg Psychiatry 2007 ; 78 : 615–619. [CrossRef] [PubMed]
  11. Holsen LM, Savage CR, Martin LE, et al. Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity. Int J Obes (Lond) 2012 ; 36 : 638–647. [CrossRef] [PubMed]
  12. Diene G, Mimoun E, Feigerlova E, et al. Endocrine disorders in children with Prader-Willi syndrome – data from 142 children of the French database. Horm Res Paediatr 2010 ; 74 : 121–128. [CrossRef] [PubMed]
  13. Deal CL, Tony M, Höybye C, et al. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 2013 ; 98 : E1072–E1087. [CrossRef] [PubMed]
  14. Festen DA, Wevers M, Lindgren AC, et al. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol 2008 ; 68 : 919–925. [CrossRef]
  15. Feigerlova E, Diene G, Oliver I, et al. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment. J Clin Endocrinol Metab 2010 ; 95 : 4600–4608. [CrossRef] [PubMed]
  16. Siemensma EP, Lind Tummers-de, van Wijngaarden RF, Festen DA, et al. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab 2012 ; 97 : 2307–2314. [CrossRef] [PubMed]
  17. Höybye C.. Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition. Acta Paediatr 2015 ; 104 : 422–427. [CrossRef]
  18. Eldar-Geva T, Hirsch HJ, Pollak Y, et al. Management of hypogonadism in adolescent girls and adult women with Prader-Willi syndrome. Am J Med Genet A 2013; 161A : 3030–3034. [CrossRef] [PubMed]
  19. Eldar-Geva T, Hirsch HJ, Benarroch F, et al. Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur J Endocrinol 2010 ; 162 : 377–384. [CrossRef] [PubMed]
  20. Eldar-Geva T, Hirsch HJ, Rabinowitz R, et al. Primary ovarian dysfunction contributes to the hypogonadism in women with Prader-Willi Syndrome. Horm Res 2009 ; 72 : 153–159. [CrossRef] [PubMed]
  21. Hirsch HJ, Eldar-Geva T, Benarroch F, et al. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab 2009 ; 94 : 2262–2268. [CrossRef] [PubMed]
  22. Hirsch HJ, Eldar-Geva T, Erlichman M, et al. Characterization of minipuberty in infants with Prader-Willi syndrome. Horm Res Paediatr 2014 ; 82 : 230–237. [CrossRef] [PubMed]
  23. Abreu AP, Dauber A, Macedo DB, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med 2013 ; 368 : 2467–2475. [CrossRef] [PubMed]
  24. Recommandations Handicap. Obésité 2013 ; 8 : 196–20
  25. Tauber M, Diene G, Mimoun E, et al. Prader-Willi syndrome as a model of human hyperphagia. Front Horm Res 2014 ; 42 : 93–106. [CrossRef] [PubMed]
  26. Studer L.. Derivation of dopaminergic neurons from pluripotent stem cells. Prog Brain Res 2012 ; 200 : 243–263. [CrossRef] [PubMed]
  27. Monnier P, Dandolo L. Rôle du locus H19 dans le placenta. Med Sci (Paris) 2013 ; 29 : 19–21. [CrossRef] [EDP Sciences]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.